Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Pommier

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Frontiers in Oncology|January 28, 2022
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective StudyIngrid Masson, Martine Bellanger, Geneviève Perrocheau, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2018
Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized TrialRenaud de Crevoisier, Mohamed Amine Bayar, Pascal Pommier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
Cost of prostate image-guided radiation therapy: results of a randomized trialLionel Perrier, Magali Morelle, Pascal Pommier, et al.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2017
Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score-Weighted AnalysisJean-Emmanuel Bibault, Sophie Dussart, Pascal Pommier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01Pascal Pommier, Sylvie Chabaud, Jean Leon Lagrange, et al.
European Urology|July 12, 2021
OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate CancerStéphane Supiot, Loig Vaugier, David Pasquier, et al.
Head & Neck|October 13, 2021
Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub-analysis of the ProfiLER protocolElise Rowinski, Nicolas Magné, Jérôme Fayette, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 12, 2021
Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: A multicentric study using propensity scoreEsteban Brenet, Pierre Philouze, Camille Schiffler, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 19, 2021
What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohortManon Bacci, Laurent Quero, Emilie Barbier, et al.
World Journal of Urology|August 31, 2013
Nomograms to predict late urinary toxicity after prostate cancer radiotherapyRomain Mathieu, Juan David Ospina Arango, Véronique Beckendorf, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|January 28, 2022
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective StudyIngrid Masson, Martine Bellanger, Geneviève Perrocheau, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2018
Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized TrialRenaud de Crevoisier, Mohamed Amine Bayar, Pascal Pommier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
Cost of prostate image-guided radiation therapy: results of a randomized trialLionel Perrier, Magali Morelle, Pascal Pommier, et al.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2017
Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score-Weighted AnalysisJean-Emmanuel Bibault, Sophie Dussart, Pascal Pommier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01Pascal Pommier, Sylvie Chabaud, Jean Leon Lagrange, et al.
European Urology|July 12, 2021
OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate CancerStéphane Supiot, Loig Vaugier, David Pasquier, et al.
Head & Neck|October 13, 2021
Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub-analysis of the ProfiLER protocolElise Rowinski, Nicolas Magné, Jérôme Fayette, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 12, 2021
Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: A multicentric study using propensity scoreEsteban Brenet, Pierre Philouze, Camille Schiffler, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 19, 2021
What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohortManon Bacci, Laurent Quero, Emilie Barbier, et al.
World Journal of Urology|August 31, 2013
Nomograms to predict late urinary toxicity after prostate cancer radiotherapyRomain Mathieu, Juan David Ospina Arango, Véronique Beckendorf, et al.
Pageof 12